ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Report Urges Heated Chemo To Optimize Patient Survival

November 24, 2006

CCOPs Favor Ability To Enter Patients On Any Group Study

June 12, 1998

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006

In Brief: Ozols Promoted At Fox Chase; Greenberger Moves To Pittsburgh; ACR Names New Officers

October 8, 1993

NCAB Members Skeptical On NCI Reorganization; King Has “Alterative;” Terry T Head Centers

January 27, 1978

NIH Will Target Genomics, Translational Research, And Training, Collins Tells Congress

April 30, 2010